mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.25 |
0.006 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.007 |